Sahajanand Medical Technologies: The financial results for the period ended September 30, 2026
Sahajanand Medical Technologies (SMT) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹4,958 crore.
What happened
Sahajanand Medical Technologies (SMT) filed a disclosure with the exchanges on 5 November 2026 at 05:04 PM titled "The financial results for the period ended September 30, 2026".
Company snapshot
Sahajanand Medical Technologies is a small-cap company, with a market value of about ₹4,958 crore.
The stock last traded at ₹487.8, against a 52-week range of ₹451.3–₹514.4 (5.2% below the high).
Promoters held 36.20% at the end of Q3 FY27; 0.01% of promoter shares were pledged. Foreign institutions owned 35.10% and domestic institutions 11.83%.
What history shows
BCEIE has no earlier results filing from this company on record since May 2026.
Market-wide, 10,790 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 5 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- Sahajanand Medical Technologies IPO: GMP, Price, Apply or Avoid
- Sahajanand Medical Technologies Ltd. Peer Comparison – Compare with Others
- Sahajanand Medical Technologies shares list at 8% premium over IPO price on NSE
- Sahajanand Medical Technologies shares debut at up to 8% premium over IPO price
- Revenue per share of Sahajanand Medical Technologies Limited – NSE:SMT
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.